The Cost Effectiveness of Treating Mild DKA in Children with Type I Diabetes Mellitus with Subcutaneous Insulin Aspart

2021 ◽  
Author(s):  
Ibrahim Bali
Keyword(s):  
Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Insulin Aspart ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
The Cost

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus

Metabolism ◽  
1989 ◽  
Vol 38 (9) ◽  
pp. 908-912 ◽  
Author(s):  
Jean-Louis Selam ◽  
Moti Kashyap ◽  
KGMM Alberti ◽  
James Lozano ◽  
Michael Hanna ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Insulin Administration

scholarly journals Analytical Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Children and Adolescents with Type I Diabetes Mellitus

2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Siddig AA ◽  
Bui TDMP ◽  
Readon DR ◽  
Ven M ◽  
Bailes Z ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Continuous Subcutaneous Insulin Infusion ◽  
Insulin Infusion ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Children And Adolescent ◽  
Multiple Daily Insulin Injections ◽  
Better Than

Introduction: Continuous subcutaneous insulin infusion (CSII) is a form of insulin administration for patients with type I diabetes mellitus (T1DM) that was introduced as a means of stimulating normal plasma insulin fluctuations and provide better metabolic control that is better than multiple daily insulin injections (MDI). The purpose of this study was to determine the effect of CSII as compared to MDI in the treatment of T1DM in children and adolescent below 20 years of age.

Sign in / Sign up

Export Citation Format

Share Document